Literature DB >> 24806733

CCL5 secreted from bone marrow stromal cells stimulates the migration and invasion of Huh7 hepatocellular carcinoma cells via the PI3K-Akt pathway.

Huili Bai1, Yaguang Weng1, Shunjie Bai1, Yingjiu Jiang2, Baolin Li1, Fang He1, Ruyi Zhang1, Shujuan Yan1, Fang Deng1, Jing Wang1, Qiong Shi1.   

Abstract

Bone metastases from hepatocellular carcinoma (HCC) seem to be increasing. Previous studies showed that soluble factors secreted by host cells and direct cell-to-cell interactions contributed to the preferential metastasis and growth of cancer cells in bone, while the underlying mechanism(s) of the metastasis of HCC in the bone are poorly understood. Here, we determined the effect of HS-5 cells on Huh7 cell proliferation, and investigated the role of CCL5 from HS-5 cells on the development of Huh7 cells. In addition, the underlying mechanisms on the influence in Huh7 cells were investigated. Our results showed that HS-5 cells could promote the proliferation, migration and invasion of Huh7 cells, and inhibited apoptosis. CCL5 downregulation was able to inhibit the effects of HS-5 cells on Huh7 cell migration and invasion via the PI3K-Akt signaling pathway and reduce MMP-2 expression. Therefore, these findings suggest that CCL5 secreted from MSCs can promote the migration and invasion of Huh7 cells and could be an important factor in HCC related to occurrence of bone metastases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24806733     DOI: 10.3892/ijo.2014.2421

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  12 in total

1.  BMP9-induced osteogenic differentiation is partially inhibited by miR-30a in the mesenchymal stem cell line C3H10T1/2.

Authors:  Ruyi Zhang; Yaguang Weng; Baolin Li; Yingjiu Jiang; Shujuan Yan; Fang He; Xiaoqing Chen; Fang Deng; Jing Wang; Qiong Shi
Journal:  J Mol Histol       Date:  2015-07-24       Impact factor: 2.611

2.  Human Cytokinome Analysis for Interferon Response.

Authors:  Suhad Al-Yahya; Linah Mahmoud; Fahad Al-Zoghaibi; Abdullah Al-Tuhami; Haithem Amer; Fahad N Almajhdi; Stephen J Polyak; Khalid S A Khabar
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

Review 3.  New therapeutic targets for cancer bone metastasis.

Authors:  Jing Y Krzeszinski; Yihong Wan
Journal:  Trends Pharmacol Sci       Date:  2015-05-09       Impact factor: 14.819

Review 4.  Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?

Authors:  Pascal David Johann; Ingo Müller
Journal:  Stem Cells Int       Date:  2015-07-27       Impact factor: 5.443

Review 5.  A top-down view of the tumor microenvironment: structure, cells and signaling.

Authors:  Rahul Bhome; Marc D Bullock; Hajir A Al Saihati; Rebecca W Goh; John N Primrose; A Emre Sayan; Alex H Mirnezami
Journal:  Front Cell Dev Biol       Date:  2015-05-29

6.  Mesenchymal stem cells in inflammatory microenvironment potently promote metastatic growth of cholangiocarcinoma via activating Akt/NF-κB signaling by paracrine CCL5.

Authors:  Wei Zhong; Yinping Tong; Yang Li; Jiahui Yuan; Shaoping Hu; Tianhui Hu; Gang Song
Journal:  Oncotarget       Date:  2017-05-11

7.  Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin.

Authors:  Carolin Mogler; Courtney König; Matthias Wieland; Anja Runge; Eva Besemfelder; Dorde Komljenovic; Thomas Longerich; Peter Schirmacher; Hellmut G Augustin
Journal:  EMBO Mol Med       Date:  2017-06       Impact factor: 12.137

8.  Microarray analysis for the identification of specific proteins and functional modules involved in the process of hepatocellular carcinoma originating from cirrhotic liver.

Authors:  Wufeng Fan; Guangming Ye
Journal:  Mol Med Rep       Date:  2018-02-02       Impact factor: 2.952

Review 9.  AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review.

Authors:  Nico Hinz; Manfred Jücker
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

10.  Key roles of necroptotic factors in promoting tumor growth.

Authors:  Xinjian Liu; Min Zhou; Ling Mei; Jiaying Ruan; Qian Hu; Jing Peng; Hang Su; Hong Liao; Shanling Liu; WeiPing Liu; He Wang; Qian Huang; Fang Li; Chuan-Yuan Li
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.